Simple blood tests to check active rheumatoid arthritis
Part of Bones, joints & muscles, Skin clinical trials.
This study looks at whether simple blood tests (like the complete blood count) can help detect when rheumatoid arthritis is active, compared with standard blood tests for inflammation. If you have RA, this could help guide your doctor in managing your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have a confirmed diagnosis of rheumatoid arthritis
- You must be willing to provide written consent to take part
- You cannot have an active infection, cancer, or another autoimmune disease
- You cannot have used steroids or immunosuppressants within the last month
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new blood test that might help doctors diagnose rheumatoid arthritis, especially for people who don't have the usual markers in their blood. It could help more people get the right diagnosis earlier.
This study is testing a new blood test that may help diagnose rheumatoid arthritis (RA) by detecting a specific antibody. If it works, it could lead to earlier and more accurate diagnosis.
This study looks at whether certain blood markers can help diagnose or monitor rheumatoid arthritis. It may help doctors better understand the disease and guide treatment.
This study looks at certain blood tests in children with juvenile idiopathic arthritis (JIA) to see if they can help measure how active the disease is. The goal is to find simpler ways to track arthritis activity and guide treatment.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This study is testing whether a simple blood test can help predict how well patients respond to anti-TNF alpha treatments (like Humira or Enbrel) for rheumatoid arthritis. If successful, this could help doctors choose the right medication sooner, saving you time and improving your quality of life.
Hear when a new Rheumatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.